Detalhe da pesquisa
1.
Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation.
Cancers (Basel);
16(5)2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473227
2.
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.
Blood;
143(7): 592-596, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048557
3.
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience.
Leuk Res;
136: 107421, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042648
4.
An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse.
Am J Hematol;
99(1): 137-141, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986135
5.
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
medRxiv;
2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38106151
6.
Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.
Front Oncol;
13: 1272072, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023169
7.
Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera.
Vasc Health Risk Manag;
19: 765-778, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38025519
8.
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents.
Haematologica;
2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981892
9.
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia.
Sci Rep;
13(1): 16950, 2023 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805613
10.
Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients.
Front Oncol;
13: 1273598, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664055
11.
Anti-ADAMTS13 Autoantibodies: From Pathophysiology to Prognostic Impact-A Review for Clinicians.
J Clin Med;
12(17)2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37685697
12.
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Br J Haematol;
203(4): e98-e101, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533098
13.
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing.
EClinicalMedicine;
60: 102016, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37396800
14.
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review.
J Clin Med;
12(14)2023 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37510704
15.
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
Clin Cancer Res;
29(19): 3901-3913, 2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449980
16.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood;
142(10): 865-877, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300386
17.
New Strategies for the Treatment of Older Myeloma Patients.
Cancers (Basel);
15(10)2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345030
18.
PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation.
Blood Adv;
7(14): 3604-3611, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163349
19.
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges.
Curr Treat Options Oncol;
24(6): 693-710, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099265
20.
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease.
J Clin Med;
12(5)2023 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902559